Rebecca Araujo

Articles by Rebecca Araujo

Rebecca AraujoRheumatology | May 28, 2024
Systemic lupus erythematosus may be related to a greater risk of pregnancy complications.
Read More
Rebecca AraujoADHD | May 20, 2024
A study evaluated a digital cognitive-physical intervention as a therapeutic option for children with ADHD.
Rebecca AraujoLupus | May 17, 2024
A study assessed factors associated with kidney involvement in patients with systemic lupus erythematosus.
Rebecca AraujoPsoriatic Arthritis | May 14, 2024
A study of real-world treatment and outcomes associated with ixekizumab found favorable efficacy in patients.
Rebecca AraujoMental Health | May 9, 2024
Xanomeline-trospium chloride is effective and well tolerated in patients with schizophrenia experiencing acute psychosis.
Rebecca AraujoRheumatology | May 3, 2024
The FDA has approved Cyltezo, for the treatment of chronic inflammatory diseases.
Rebecca AraujoDepression | April 29, 2024
A study investigated the impact of sleep duration and daily well-being in adults with depression.
Rebecca AraujoADHD | April 22, 2024
There is variation in the heritability of ASD between men and women.
Rebecca AraujoPsoriatic Arthritis | April 19, 2024
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Rebecca AraujoPsoriatic Arthritis | April 17, 2024
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Rebecca AraujoDepression | April 17, 2024
A family history of treatment-resistant depression is a risk factor for resistance to antidepressants.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients with a history of venous thromboembolism were more likely to receive VTE prophylaxis.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Rates of treatment-related hypersensitivity reactions were low in an academic community setting.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Same-day administration of pegfilgrastim was not linked to a greater incidence of grade ≥3 neutropenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Lenvatinib plus pembrolizumab led to a clinically relevant response in patients with baseline metastasis.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Higher average talazoparib concentrations were associated with an increased risk of severe anemia and thrombocytopenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Protected administrative time was ranked as the most important change to improve well-being.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
Ibrutinib dose reductions were associated with fewer recurrent cardiac adverse events in patients with B-cell malignancies.